Sharon Benzeno Adaptive Biotechnologies Corp (ADPT) insider trading activity
Sharon Benzeno is Chief Commercial Ofc Imm Med of Adaptive Biotechnologies Corp. Currently has a direct ownership of 392,723 shares of ADPT, which is worth approximately $4.18 Million. The most recent transaction as insider was on Dec 01, 2020, when has been sold 6,770 shares (Common Stock) at a price of $48.82 per share, resulting in proceeds of $330,511. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
393K
0%
3M change
19.95%
12M change
Total Value Held
$4.18 Million
SHARON BENZENO Transaction History
SB
Sharon Benzeno
Chief Commercial Ofc Imm Med
Seattle, WA